Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast CancerAyaka Okamoto, Naoto Oku, Hiroyuki Koide et al.|Molecular Pharmaceutics|2018Cited by 77
Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA deliveryYusuke Hirai, Tomohiro Asai, Saeki Ryoko et al.|International Journal of Pharmaceutics|2020Cited by 40